Prot# H9H-MC-JBAK: Randomized Phase 2 Study of LY2157299 in Patients with Hepatocellular Carcinoma who Have Had Disease Progression on Sorafenib or Are Not Eligible to Receive Sorafenib

Project: Research project

Project Details

StatusFinished
Effective start/end date7/28/11 → 2/5/16

Funding

  • Lilly USA, LLC (H9H-MC-JBAK)